Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2007; 13(29): 3918-3924
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3918
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3918
Seattle criteria | |
At least two of the three following criteria: within the first month after stem cell transplantation (STC): | |
1 | Jaundice |
2 | Hepatomegaly and right upper quadrant pain |
3 | Ascites and/or unexplained weight gain |
Baltimore criteria | |
Elevated total serum bilirubin (≥ 2 mg/dL) before d 21 after SCT and two of the following three criteria: | |
1 | Tender hepatomegaly |
2 | Weight gain ≥ 5% from baseline |
3 | Ascites |
Modified Seattle criteria | |
Occurrence of two of the following events within 20 d of SCT: | |
1 | Hyperbilirubinaemia (≥ 2 mg/dL) |
2 | Hepatomegaly or right upper quadrant pain of liver origin |
3 | Unexplained weight gain (> 2% of baseline bodyweight) because of fluid accumulation |
- Citation: Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs A. Veno occlusive disease: Update on clinical management. World J Gastroenterol 2007; 13(29): 3918-3924
- URL: https://www.wjgnet.com/1007-9327/full/v13/i29/3918.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i29.3918